CONCLUDING RESULTS OF THE LONG-TERM PHASE-2 EXTENSION STUDY (LTE) WITH BELATACEPT AFTER KIDNEY TRANSPLANT

被引：0
|
作者：
Muehlbacher, F. [1 ]
Larsen, C. [2 ]
Grinyo, J. [3 ]
Charpentier, B. [4 ]
Blancho, G. [5 ]
Grannas, G. [6 ]
Jones-Burton, C. [7 ]
Vincenti, F. [8 ]
机构：
[1] Med Univ Wien, Vienna, Austria
[2] Emory Univ, Atlanta, GA 30322 USA
[3] Univ Krankenhaus Bellvitge, Barcelona, Spain
[4] Univ Krankenhaus Nantes, Nantes, France
[5] Univ Krankenhaus Bicetre, Le Kremlin Bicetre, France
[6] Hannover Med Sch, Hannover, Germany
[7] Bristol Myers Squibb, New York, NY USA
[8] UCSF, San Francisco, CA 94117 USA
来源：
TRANSPLANT INTERNATIONAL | 2014年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
066
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [1] Final Results from the Long-Term Extension (LTE) of the Belatacept Phase 2 Study in Kidney Transplantation
    Vincenti, Flavio
    Larsen, Christian
    Grinyo, Josep
    Muehlbacher, Ferdinand
    Blancho, Gilles
    Grannas, Gerrit
    Meier-Kriesche, Ulf
    Charpentier, Bernard
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 : 58 - 58
  • [2] FINAL RESULTS FROM THE LONG-TERM EXTENSION (LTE) OF THE BELATACEPT PHASE 2 STUDY IN KIDNEY TRANSPLANTATION
    Grannas, G.
    Larsen, C.
    Grinyo, J.
    Muehlbacher, F.
    Blancho, G.
    Charpentier, B.
    Jones-Burton, C.
    Vincenti, F.
    TRANSPLANT INTERNATIONAL, 2014, 27 : 22 - 22
  • [3] Final Results from the Long-term Extension (LTE) of the Belatacept Phase 2 Study in Kidney Transplantation
    Vincenti, Flavio
    Larsen, Christian
    Grinyo, Josep
    Muehlbacher, Ferdinand
    Blancho, Gilles
    Grannas, Gerrit
    Meier-Kriesche, Ulf
    Charpentier, Bernard
    SWISS MEDICAL WEEKLY, 2014, 144 : 4S - 5S
  • [4] FINAL RESULTS FROM THE LONG-TERM EXTENSION (LTE) OF THE BELATACEPT PHASE 2 STUDY IN KIDNEY TRANSPLANTATION
    Charpentier, B.
    Larsen, C.
    Grinyo, J.
    Muehlbacher, F.
    Blancho, G.
    Grannas, G.
    Meier-Kriesche, U.
    Vincenti, F.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 7 - 7
  • [5] Final Results From the Long-Term Extension (LTE) of the Belatacept Phase 2 Study in Kidney Transplantation.
    Charpentier, B.
    Larsen, C.
    Grinyo, J.
    Muehlbacher, F.
    Blancho, G.
    Grannas, G.
    Jones-Burton, C.
    Vincenti, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 117 - 117
  • [6] Final Results From the Long-Term Extension (LTE) of the Belatacept Phase 2 Study in Kidney Transplantation.
    Charpentier, B.
    Larsen, C.
    Grinyo, J.
    Muehlbacher, F.
    Blancho, G.
    Grannas, G.
    Jones-Burton, C.
    Vincenti, F.
    TRANSPLANTATION, 2014, 98 : 117 - 117
  • [7] RENAL FUNCTION AT 2 YEARS IN KIDNEY TRANSPLANT RECIPIENTS SWITCHED FROM CYCLCOSPORINE OR TACROLIMUS TO BELATACEPT: RESULTS FROM THE LONG-TERM EXTENSION OF A PHASE II STUDY
    Grinyo, Josep
    Nainan, Georgy
    del Carmen Rial, Maria
    Steinberg, Steven
    Vincenti, Flavio
    Dong, Yuping
    Thomas, Dolca
    Kamar, Nassim
    TRANSPLANT INTERNATIONAL, 2011, 24 : 70 - 70
  • [8] Renal Function at 2 Years in Kidney Transplant Recipients Switched from Cyclosporine or Tacrolimus to Belatacept: Results from the Long-Term Extension of a Phase II Study
    Grinyo, J.
    Nainan, G.
    Rial, M.
    Steinberg, S.
    Vincenti, F.
    Dong, Y.
    Thomas, D.
    Kamar, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 99 - 99
  • [9] LONG-TERM BELATACEPT MAINTAINS EFFICACY & SAFETY: 5-YEAR BENEFIT LONG-TERM EXTENSION (LTE) RESULTS
    Rostaing, Lionel
    Vincenti, Flavio
    Grinyo, Josep M.
    Rice, Kim
    Steinberg, Steven M.
    Gaite, Luis
    Moal, Marie-Christine
    Pupim, Lara
    Larsen, Christian
    TRANSPLANT INTERNATIONAL, 2013, 26 : 44 - 44
  • [10] LONG-TERM BELATACEPT MAINTAINS EFFICACY AND SAFETY: 5-YEAR BENEFIT LONG-TERM EXTENSION (LTE) RESULTS
    Rostaing, L.
    Vincenti, F.
    Grinyo, J. M.
    Rice, K. M.
    Steinberg, S. M.
    Gaite, L. E.
    Moal, M. C.
    Pupim, L.
    Larsen, C. P.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 2 - 3
12345